IP Verse

Elanco New Zealand competitive analysis

Latest publications and patents of Elanco New Zealand New

Explore the latest publications and patents granted to Elanco New Zealand, showcasing their recent innovations and technological advancements.

Last updated on: Sep 26, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Elanco New Zealand
EP2819699	Oct 16, 2024	Controlled Release Compositions And Their Methods Of Use	Patent Maintained As Amended
EP2874624	Oct 2, 2019	Injectable Antibiotic Formulations And Their Methods Of Use	Opposition Rejected

Latest patents of Elanco New Zealand opposed by its competitors

Explore Elanco New Zealand's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP2819699	Oct 16, 2024	Controlled Release Compositions And Their Methods Of Use	1
EP2874624	Oct 2, 2019	Injectable Antibiotic Formulations And Their Methods Of Use	2

Latest PTAB cases involving Elanco New Zealand

Discover the latest PTAB cases involving Elanco New Zealand, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Elanco New Zealand with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
ELANCO NEW ZEALAND	-	3	-	-	Non-Active
BOEHRINGER INGELHEIM ANIMAL HEALTH USA	16	30	2	-	Balanced
EUROVET ANIMAL HEALTH	1	-	-	-	Highly Aggressive
OMNIPHARM DEVELOPMENTS	1	-	-	-	Highly Aggressive